Molecular phenotypes of DCIS predict overall and invasive recurrence.
AffiliationDepartment of Academic Surgery, University Hospital of South Manchester, Manchester, United Kingdom
MetadataShow full item record
AbstractMolecular phenotypes of invasive breast cancer predict early recurrence. DCIS exhibits similar phenotypes but their frequency and significance remain unclear. To determine whether DCIS molecular phenotypes predict recurrence, 314 women (median age 57.7 years) with primary DCIS who were screened or entered DCIS trials in a specialist breast unit from 1990-2010 were studied.
CitationMolecular phenotypes of DCIS predict overall and invasive recurrence. 2015: Ann Oncol
JournalAnnals of Oncology
- Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
- Authors: Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD
- Issue date: 2010 May 5
- Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
- Authors: Merkin RD, Vanner EA, Romeiser JL, Shroyer ALW, Escobar-Hoyos LF, Li J, Powers RS, Burke S, Shroyer KR
- Issue date: 2017 Apr
- Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.
- Authors: Zhou W, Jirström K, Johansson C, Amini RM, Blomqvist C, Agbaje O, Wärnberg F
- Issue date: 2010 Nov 30
- Outcome evaluation in pre-trastuzumab era between different breast cancer phenotypes: a population-based study on Italian women.
- Authors: Cortesi L, De Matteis E, Cirilli C, Marcheselli L, Proietto M, Federico M
- Issue date: 2012 Nov
- Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information.
- Authors: Feeley LP, Mulligan AM, Pinnaduwage D, Bull SB, Andrulis IL
- Issue date: 2014 Apr